HOME >> MEDICINE >> NEWS
Advances In Translational Cancer Research Is Focus Of 90th Annual Meeting Of American Association For Cancer Research

Philadelphia, March 30, 1999 -- Cancer researchers from around the world will meet in April at the 90th Annual Meeting of American Association for Cancer Research (AACR) to share cutting-edge research findings in the rapidly advancing areas of translational research and molecular genetics, including anti-angiogenesis agents, cancer vaccines, gene therapy, and molecular targeted therapy. The meeting will take place from April 10-14 at the Pennsylvania Convention Center in Philadelphia, and will feature close to 5,000 abstracts and 200 invited presentations. Two special late-breaking research sessions will offer reports of highly significant and timely findings that have occurred within the last few months. A new feature at the Annual Meeting is a special lecture, given this year by Nobel Laureate James D. Watson, Ph.D., entitled "From the Double Helix to DNA Tumor Viruses."

"As the pace of scientific discovery accelerates, it is essential to present the most up-to-date and novel information to the scientific community and the public in order to make progress against cancer," said Webster K. Cavenee Ph.D., President of AACR and Director, Ludwig Institute for Cancer Research in La Jolla, CA. "To that end, we have been closely monitoring scientific developments and will present research on the latest research findings in all of the subdisciplines of cancer research."

"For the last five months, the 90th Annual Meeting Program Committee has been working to examine the entire field of cancer research and identify the most rapidly developing research areas, as well as the most appropriate scientists to organize the sessions in which these new data will be presented," said Waun Ki Hong, M.D., American Cancer Society Clinical Research Professor, Professor and Chairman, Department of Thoracic/Head and Neck Oncology, UT M.D. Anderson Cancer Center, Charles A. LeMaistre Distinguished Chair in Thoracic Oncology, Chairperson of the AACR Program C
'"/>

Contact: Jack Cooley
jcooley@cwg.com
212-886-2200
Cooney Waters Group, Inc.
4-Apr-1999


Page: 1 2 3 4

Related medicine news :

1. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
2. Advances in plasma physics at Annual APS Meeting
3. Advances in plasma physics at Annual APS Meeting
4. Advances in understanding brain circuits responsible for tics in Tourettes shed light on disorder
5. Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis: A scientific meeting
6. Advances emerging in hepatitis management
7. Advances in prevention and treatment research hold promise for pipeline
8. Advances in MRI imaging may lead to new standards for faster diagnosis of multiple sclerosis
9. Peanut Allergy: Major Advances in Treatment and Education
10. "Radical" Discovery Advances Medicine and Plastics
11. Advances in On the Spot tests have huge public health implications

Post Your Comments:
(Date:5/24/2015)... Scientists with Cardno ChemRisk, a scientific consulting firm, ... that may have raised the risk of mesothelioma for ... an article on the research. Click here to ... asbestos levels well above OSHA safety guidelines when they ... “Asbestos compliance sampling data associated with the construction, automotive ...
(Date:5/24/2015)... York (PRWEB) May 24, 2015 ... lawsuits ( http://www.testosteronelawsuithub.com/ ) has scheduled its next ... of the multidistrict litigation. According to court documents ... of Illinois, the Conference will be convened on ... Testosterone Replacement Therapy Product Liability Litigation - MDL ...
(Date:5/24/2015)... Indiana Fiber Network, LLC (IFN), the leading Indiana ... Inc. (MTA) has selected IFN as a fiber transport ... Sales Manager, fiber route diversity and network redundancy are ... MTA with the diverse fiber transport from their Merrillville ... voice carriers located at Henry Street in Indianapolis, IN. ...
(Date:5/24/2015)... May 24, 2015 ... CEO - The students were ... at the fourth annual A Day ... at Geneva National in Lake Geneva. ...     -Badger High School,         Jonathan Alfonso,         Bridget ...
(Date:5/23/2015)... Florida City, FL (PRWEB) May 23, 2015 ... together to build a new playground for Branches Florida City ... destroyed the former play space in 2010. , A large ... then new playground on May 23, 2010 in the middle ... families watched. The fire was later declared arson even though ...
Breaking Medicine News(10 mins):Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 2Health News:Testosterone Lawsuit Attorneys at Bernstein Liebhard LLP Look Ahead to June Conference in Federal Multidistrict Litigation 3Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Five Years After Fire, Branches Rebuilds Playground 2
(Date:5/22/2015)... , May 22, 2015  Research and ... its sixth Medical Affairs Roundtable on ... via a virtual roundtable to discuss "Medical Affairs, ... Best Practices, Medical Affairs Consortium provides Medical ... about the key challenges they face. The consortium ...
(Date:5/22/2015)... TORONTO , May 22 2015 /CNW/ - The Taskforce ... are very appreciative of all the hard work that the ... the past six months. This program recognizes the needs of ... receive at least $75,000 a year, tax free, with annual ... will be eligible for annual payments of $100,000 based on ...
(Date:5/22/2015)... OAKS, Calif. , May 22, 2015 ... announced the Company has commenced termination of ... of brodalumab with AstraZeneca (LON:AZN, STO:AZN and ... IL-17 inhibitor, is in development for patients ... axial spondyloarthritis.  The decision was based on ...
Breaking Medicine Technology:Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes Research 2Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5
Cached News: